Kelman Lazarov Inc. bought a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 3,490 shares of the company’s stock, valued at approximately $448,000.
Several other hedge funds also recently made changes to their positions in MKGAF. Addison Advisors LLC acquired a new stake in shares of Merck KGaA in the second quarter valued at approximately $90,000. Comprehensive Financial Planning Inc. PA acquired a new stake in Merck KGaA during the second quarter worth approximately $134,000. Stevens Capital Partners acquired a new stake in Merck KGaA during the second quarter worth approximately $220,000. BOK Financial Private Wealth Inc. acquired a new stake in Merck KGaA during the second quarter worth approximately $523,000. Finally, one8zero8 LLC bought a new position in Merck KGaA during the 2nd quarter worth $830,000. 0.10% of the stock is owned by institutional investors.
Merck KGaA Price Performance
Shares of OTCMKTS MKGAF opened at $167.38 on Thursday. The stock has a market capitalization of $21.63 billion, a PE ratio of 25.55 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The business has a fifty day moving average price of $162.50 and a two-hundred day moving average price of $148.28. Merck KGaA has a fifty-two week low of $116.68 and a fifty-two week high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
See Also
- Five stocks we like better than Merck KGaA
- Bloom Energy’s AI Surge Meets a Valuation Reality Check
- Target Is Winning Shoppers Back—Can the Rally Reach $180?
- IonQ’s Space Contract Points to a New Frontier for Quantum Investors
- Is Apple’s AI Strategy Smarter Than Skeptics Think?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
